Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
$3.67
$11.07
$35.71
$11.99M1.183,849 shs3,700 shs
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
C$0.75
-2.6%
C$0.75
C$0.50
C$1.65
C$12.32MN/A7,643 shs4,571 shs
Kenon Holdings Ltd. stock logo
KEN
Kenon
$21.57
-0.5%
$24.28
$17.64
$30.65
$1.16B1.4522,270 shs5,718 shs
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
$29.53
$29.53
$15.33
$29.53
$11.81MN/A921 shsN/A
RAK
Rackla Metals
C$0.17
-10.5%
C$0.13
C$0.08
C$0.40
C$12.14M1.57105,726 shs230,000 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
0.00%0.00%-11.90%+4,340.00%+2,632.31%
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
0.00%0.00%0.00%0.00%0.00%
Kenon Holdings Ltd. stock logo
KEN
Kenon
-0.46%+3.75%-14.84%-12.39%-18.57%
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
0.00%0.00%0.00%0.00%0.00%
RAK
Rackla Metals
-10.53%+6.25%+47.83%+70.00%-22.73%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
N/AN/AN/AN/AN/AN/AN/AN/A
Kenon Holdings Ltd. stock logo
KEN
Kenon
0.6393 of 5 stars
0.04.01.70.02.30.00.6
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
N/AN/AN/AN/AN/AN/AN/AN/A
RAK
Rackla Metals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
N/AN/AN/AN/A
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
N/AN/AN/AN/A
Kenon Holdings Ltd. stock logo
KEN
Kenon
N/AN/AN/AN/A
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
0.00
N/AN/AN/A
RAK
Rackla Metals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
$140K0.00N/AN/A($16.07) per share0.00
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
N/AN/AC$0.00 per share870.00C$0.21 per shareN/A
Kenon Holdings Ltd. stock logo
KEN
Kenon
$691.80M1.68N/AN/A$38.42 per share0.56
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
N/AN/AN/AN/AN/AN/A
RAK
Rackla Metals
N/AN/AC$0.02 per share9.60C$0.04 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
-$14.80M-$13.03N/AN/AN/A-10,424.65%N/A-120.90%5/13/2024 (Estimated)
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
N/A-C$0.05N/AN/AN/AN/AN/AN/A
Kenon Holdings Ltd. stock logo
KEN
Kenon
-$235.98M-$4.42N/AN/A-34.10%-10.82%-5.80%6/3/2024 (Estimated)
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
N/AN/A0.00N/AN/AN/AN/AN/A
RAK
Rackla Metals
-C$4.19M-C$0.08N/AN/AN/A-212.41%-121.95%N/A

Latest DJI, AGE, KEN, PSM, and RAK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
Kenon Holdings Ltd. stock logo
KEN
Kenon
N/A$0.11+$0.11$0.11N/A$151.00 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
N/AN/AN/AN/AN/A
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
N/AN/AN/AN/AN/A
Kenon Holdings Ltd. stock logo
KEN
Kenon
$3.8017.62%N/AN/A 1 Years
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
$0.431.46%N/AN/AN/A
RAK
Rackla Metals
N/AN/AN/AN/AN/A

Latest DJI, AGE, KEN, PSM, and RAK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/26/2024
Kenon Holdings Ltd. stock logo
KEN
Kenon
--$3.8010.5%4/5/20244/8/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
N/A
0.13
0.36
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
7.99
0.14
0.08
Kenon Holdings Ltd. stock logo
KEN
Kenon
0.66
3.05
3.05
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
N/AN/AN/A
RAK
Rackla Metals
1.00
2.98
6.93

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AgeX Therapeutics, Inc. stock logo
AGE
AgeX Therapeutics
51.08 million1.01 millionNot Optionable
Dajin Lithium Corp. stock logo
DJI
Dajin Lithium
N/A16.43 millionN/ANot Optionable
Kenon Holdings Ltd. stock logo
KEN
Kenon
32553.89 million53.81 millionOptionable
PSM
Principal U.S. Small-MidCap Multi-Factor ETF
N/A400,000N/ANot Optionable
RAK
Rackla Metals
N/A71.38 millionN/ANot Optionable

DJI, AGE, KEN, PSM, and RAK Headlines

SourceHeadline
Rackla Metals Inc. (CVE:RAK) Director Purchases C$57,475.00 in StockRackla Metals Inc. (CVE:RAK) Director Purchases C$57,475.00 in Stock
insidertrades.com - March 22 at 10:44 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AgeX Therapeutics logo

AgeX Therapeutics

NYSE:AGE
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Dajin Lithium logo

Dajin Lithium

CVE:DJI
Dajin Lithium Corp., together with its subsidiaries, primarily engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Argentina. It explores for lithium, potash, and boron minerals. The company holds a 100% interest in Teels Marsh Project that covers 403 placer mineral claims covering an area of approximately 3,202 hectares located in the Teels Marsh valley of Mineral County, Nevada; and Alkali Lake project, which includes 62 placer mineral claims situated in the Alkali Spring valley of Esmeralda county, Nevada. It also holds 49% interests in the Salinas Grandes Salar project that covers an area of 93,000 hectares located in the Jujuy province, Argentina. The company was formerly known as Dajin Resources Corp. and changed its name to Dajin Lithium Corp. in January 2020. Dajin Lithium Corp. was incorporated in 1987 and is based in Vancouver, Canada.
Kenon logo

Kenon

NYSE:KEN
Kenon Holdings Ltd., through its subsidiaries, operates as an owner, developer, and operator of power generation facilities in Israel, the United States, and internationally. It operates through OPC Power Plants, CPV Group, and ZIM segments. The company engages in the generation and supply of electricity and energy; development, construction, and management of solar and wind energy, and conventional natural gas-fired power plants; and provision of container liner shipping services. It also operates a fleet of 150 vessels. Kenon Holdings Ltd. was incorporated in 2014 and is based in Singapore. Kenon Holdings Ltd. operates as a subsidiary of Ansonia Holdings Singapore B.V.

Principal U.S. Small-MidCap Multi-Factor ETF

NASDAQ:PSM

Rackla Metals

CVE:RAK
Rackla Metals Inc., a junior gold exploration company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company holds a 100% interest in the Rivier property located in the Watson Lake Mining District, Yukon. It also holds interests in the Tombstone Gold Belt projects situated in Yukon and Northwest Territories. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.